Concourse Financial Group Securities, Inc. Genetic Technologies LTD Call Options Transaction History
Concourse Financial Group Securities, Inc.
- $1.64 Billion
- Q3 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
About GENETIC TECHNOLOGIES LTD
- Ticker GENE
- Exchange OTC
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 15,389,900
- Market Cap $11.9M
- Description
- Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage women's health in Australia and the United States. The company's lead product is the BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to ...